D
Nurix Therapeutics, Inc. NRIX
$13.59 $0.403.03%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

11/30/2024 08/31/2024
Revenue 5.53% 4.10%
Total Other Revenue -- --
Total Revenue 5.53% 4.10%
Cost of Revenue 21.17% 13.41%
Gross Profit -25.75% -16.46%
SG&A Expenses -8.54% 0.07%
Depreciation & Amortization -- --
Other Operating Expenses -- --
Total Operating Expenses 15.99% 10.83%
Operating Income -18.40% -12.51%
Income Before Tax -19.78% -9.94%
Income Tax Expenses -90.24% -8.89%
Earnings from Continuing Operations -19.60% -9.90%
Earnings from Discontinued Operations -- --
Extraordinary Item & Accounting Change -- --
Minority Interest in Earnings -- --
Net Income -19.60% -9.90%
EBIT -18.40% -12.51%
EBITDA -21.43% -13.00%
EPS Basic -11.00% 5.80%
Normalized Basic EPS -11.17% 5.77%
EPS Diluted -11.00% 5.80%
Normalized Diluted EPS -11.17% 5.77%
Average Basic Shares Outstanding 7.74% 16.68%
Average Diluted Shares Outstanding 7.74% 16.68%
Dividend Per Share -- --
Payout Ratio -- --
Weiss Ratings